1.
Yousefi F, Kamyab P, Fakhraei B, Farjam M, Rezaei S, Mahmoudi SS, et al. The Effects of Selective Serotonin Reuptake Inhibitors on Neurological and Depressive Symptoms in Multiple Sclerosis: A Systematic Review and Meta‐analysis of Randomized Controlled Trials: SSRIs in Multiple Sclerosis: Meta-analysis: SSRIs in Multiple Sclerosis: Meta-analysis. Galen Med J [Internet]. 2023 Dec. 18 [cited 2024 Dec. 25];12:e3153. Available from: https://journals.salviapub.com/index.php/gmj/article/view/3153